Pulmonary expression of oncostatin M (OSM) promotes inducible BALT formation independently of IL-6, despite a role for IL-6 in OSM-driven pulmonary inflammation

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1453-1464

  Botelho, Fernando M ^a,b   Rangel Moreno, Javier ^c   Fritz, Dominik ^d   Randall, Troy D ^c,e   Xing, Zhou ^a   Richards, Carl D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CXCL13 CHEMOKINE; EOTAXIN 2; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOSTATIN M; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE; INFLAMMATORY CELL; LUNG; LYMPHOID TISSUE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINES; CYTOKINES; HELA CELLS; HUMANS; INTERLEUKIN-6; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ONCOSTATIN M; PNEUMONIA; STAT6 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 84880652115     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203318     Document Type: Article

References (39)

1. Silver, J. S., and C. A. Hunter. 2010. gp130 at the nexus of inflammation, autoimmunity, and cancer. J. Leukoc. Biol. 88: 1145-1156.
2. Heinrich, P. C., I. Behrmann, S. Haan, H. M. Hermanns, G. Müller-Newen, and F. Schaper. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374: 1-20.
3. Tanaka, M., and A. Miyajima. 2003. Oncostatin M, a multifunctional cytokine. Rev. Physiol. Biochem. Pharmacol. 149: 39-52.
4. Faffe, D. S., L. Flynt, M. Mellema, P. E. Moore, E. S. Silverman, V. Subramaniam, M. R. Jones, J. P. Mizgerd, T. Whitehead, A. Imrich, et al. 2005. Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13. J. Allergy Clin. Immunol. 115: 514-520.
5. Fritz, D. K., C. Kerr, L. Tong, D. Smyth, and C. D. Richards. 2006. Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6. J. Immunol. 176: 4352-4360.
6. Hintzen, C., C. Haan, J. P. Tuckermann, P. C. Heinrich, and H. M. Hermanns. 2008. Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8, chemokine expression. J. Immunol. 181: 7341-7349.
7. Lafontant, P. J., A. R. Burns, E. Donnachie, S. B. Haudek, C. W. Smith, and M. L. Entman. 2006. Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 291: C18-C26.
8. Langdon, C., C. Kerr, L. Tong, and C. D. Richards. 2003. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice. J. Immunol. 170: 548-555.
9. Simpson, J. L., K. J. Baines, M. J. Boyle, R. J. Scott, and P. G. Gibson. 2009. Oncostatin M (OSM) is increased in asthma with incompletely reversible airflow obstruction. Exp. Lung Res. 35: 781-794.
10. Kang, H. J., J. S. Kang, S. H. Lee, S. J. Hwang, S. W. Chae, J.-S. Woo, and H.-M. Lee. 2005. Upregulation of oncostatinM in allergic rhinitis. Laryngoscope 115: 2213-2216.
11. Mozaffarian, A., A. W. Brewer, E. S. Trueblood, I. G. Luzina, N. W. Todd, S. P. Atamas, and H. A. Arnett. 2008. Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. J. Immunol. 181: 7243-7253.
12. Nightingale, J., S. Patel, N. Suzuki, R. Buxton, K. I. Takagi, J. Suzuki, Y. Sumi, A. Imaizumi, R. M. Mason, and Z. Zhang. 2004. Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J. Am. Soc. Nephrol. 15: 21-32.
13. Goren, I., H. Kämpfer, E. Müller, D. Schiefelbein, J. Pfeilschifter, and S. Frank. 2006. Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetesimpaired wounds. J. Invest. Dermatol. 126: 628-637.
14. Jung, I. D., K. T. Noh, C.-M. Lee, S. H. Chun, S. K. Jeong, J. W. Park, W. S. Park, H. W. Kim, C.-H. Yun, Y. K. Shin, and Y.-M. Park. 2010. Oncostatin M induces dendritic cell maturation and Th1 polarization. Biochem. Biophys. Res. Commun. 394: 272-278.
15. Louis, I., G. Dulude, S. Corneau, S. Brochu, C. Boileau, C. Meunier, C. Cǒté, N. Labrecque, and C. Perreault. 2003. Changes in the lymph node microenvironment induced by oncostatin M. Blood 102: 1397-1404.
16. Clegg, C. H., H. S. Haugen, J. T. Rulffes, S. L. Friend, and A. G. Farr. 1999. Oncostatin M transforms lymphoid tissue function in transgenic mice by stimulating lymph node T-cell development and thymus autoantibody production. Exp. Hematol. 27: 712-725.
17. Goya, S., H. Matsuoka, M. Mori, H. Morishita, H. Kida, Y. Kobashi, T. Kato, Y. Taguchi, T. Osaki, I. Tachibana, et al. 2003. Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung. J. Pathol. 200: 82-87.
18. Foo, S. Y., and S. Phipps. 2010. Regulation of inducible BALT formation and contribution to immunity and pathology. Mucosal Immunol. 3: 537-544.
19. GeurtsvanKessel, C. H., M. A. Willart, I. M. Bergen, L. S. van Rijt, F. Muskens, D. Elewaut, A. D. Osterhaus, R. Hendriks, G. F. Rimmelzwaan, and B. N. Lambrecht. 2009. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206: 2339-2349.
20. Moyron-Quiroz, J. E., J. Rangel-Moreno, K. Kusser, L. Hartson, F. Sprague, S. Goodrich, D. L. Woodland, F. E. Lund, and T. D. Randall. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10: 927-934.
21. Rangel-Moreno, J., L. Hartson, C. Navarro, M. Gaxiola, M. Selman, and T. D. Randall. 2006. Inducible bronchus-Associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest. 116: 3183-3194.
22. Kahnert,A.,U. E. Höpken,M. Stein, S. Bandermann, M. Lipp, and S. H. E.Kaufmann. 2007. Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs. J. Infect. Dis. 195: 46-54.
23. Bánfi, A., L. Tiszlavicz, E. Székely, F. Peták, V. Tóth-Szüki, L. Baráti, F. Bari, and Z. Novák. 2009. Development of bronchus-Associated lymphoid tissue hyperplasia following lipopolysaccharide-induced lung inflammation in rats. Exp. Lung Res. 35: 186-197.
24. Fleige, H., J. D. Haas, F. R. Stahl, S. Willenzon, I. Prinz, and R. Fö rster. 2011. Induction of BALT in the absence of IL-17. Nat. Immunol. 13: 1; author reply 2.
25. Fritz, D. K., C. Kerr, R. Fattouh, A. Llop-Guevara, W. I. Khan, M. Jordana, and C. D. Richards. 2011. A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent. J. Immunol. 186: 1107-1118.
26. Rangel-Moreno, J., D. M. Carragher, M. de la Luz Garcia-Hernandez, J. Y. Hwang, K. Kusser, L. Hartson, J. K. Kolls, S. A. Khader, and T. D. Randall. 2011. The development of inducible bronchus-Associated lymphoid tissue depends on IL-17. Nat. Immunol. 12: 639-646.
27. Xing, Z., T. Braciak, M. Jordana, K. Croitoru, F. L. Graham, and J. Gauldie. 1994. Adenovirus-mediated cytokine gene transfer at tissue sites: overexpression of IL-6 induces lymphocytic hyperplasia in the lung. J. Immunol. 153: 4059-4069.
28. Bilsborough, J., S. Mudri, E. Chadwick, B. Harder, and S. R. Dillon. 2010. IL-31 receptor (IL-31RA) knockout mice exhibit elevated responsiveness to oncostatin M. J. Immunol. 185: 6023-6030.
29. Rangel-Moreno, J., J. E. Moyron-Quiroz, L. Hartson, K. Kusser, and T. D. Randall. 2007. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc. Natl. Acad. Sci. USA 104: 10577-10582.
30. Schutyser, E., S. Struyf, and J. Van Damme. 2003. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14: 409-426.
31. McDermott, M. R., A. D. Befus, and J. Bienenstock. 1982. The structural basis for immunity in the respiratory tract. Int. Rev. Exp. Pathol. 23: 47-112.
32. Cawston, T. E., V. A. Curry, C. A. Summers, I. M. Clark, G. P. Riley, P. F. Life, J. R. Spaull, M. B. Goldring, P. J. Koshy, A. D. Rowan, and W. D. Shingleton. 1998. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum. 41: 1760-1771.
33. Marchal-Sommé, J., Y. Uzunhan, S. Marchand-Adam, D. Valeyre, V. Soumelis, B. Crestani, and P. Soler. 2006. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J. Immunol. 176: 5735-5739.
34. Elliot, J. G., C. M. Jensen, S. Mutavdzic, J. P. Lamb, N. G. Carroll, and A. L. James. 2004. Aggregations of lymphoid cells in the airways of nonsmokers, smokers, and subjects with asthma. Am. J. Respir. Crit. Care Med. 169: 712-718.
35. Wang, J., D. P. Snider, B. R. Hewlett, N. W. Lukacs, J. Gauldie, H. Liang, and Z. Xing. 2000. Transgenic expression of granulocyte-macrophage colonystimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung. Blood 95: 2337-2345.
36. Yoshida, M., J. Sakuma, S. Hayashi, K. Abe, I. Saito, S. Harada, M. Sakatani, S. Yamamoto, N. Matsumoto, Y. Kaneda, et al. 1995. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene. Proc. Natl. Acad. Sci. USA 92: 9570-9574.
37. Sugaya, M., L. Fang, A. R. Cardones, T. Kakinuma, S. H. Jaber, A. Blauvelt, and S. T. Hwang. 2006. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J. Immunol. 177: 7665-7672.
38. Le Borgne, M., N. Etchart, A. Goubier, S. A. Lira, J.-C. Sirard, N. van Rooijen, C. Caux, S. Aït-Yahia, A. Vicari, D. Kaiserlian, and B. Dubois. 2006. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24: 191-201.
39. Nurieva, R. I., Y. Chung, D. Hwang, X. O. Yang, H. S. Kang, L. Ma, Y.-H. Wang, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29: 138-149.